Gapping down
In reaction to disappointing earnings/guidance:
- POWL -14.5% (thinly traded), PLAY -13.3%, AEO -7.3%, ARWR -0.9%, PLAB -0.8%
Other news:
- NBIX -19.5% (announces topline data from the Phase IIb T-Force GOLD study -- valbenazine did not meet primary endpoint)
- MRNS -10.2% (announces 12 mln share offering)
- MNK -9.3% (receives complete response letter from the FDA for the New Drug Application for its investigational abuse-deterrent, immediate-release reformulation of Roxicodone
- FLDM -9.1% (prices public offering of 8,150,000 shares of its common stock at a price to the public of $6.75 per share)
- GMRE -6.7% (commenced public offering of common stock)
- LAND -6.5% (announced that it plans to sell shares of its common stock in an underwritten public offering)
- TOCA -4.1% (announces underwritten public offering of 3.0 mln shares of its common stock)
- NEO -2.2% (announces secondary offering of 10,835,145 shares of common stock by secondary shareholders)
- LUV -1.1% (provides update on Q4 financial and operational trends, continues to expect RASM to increase 1-2%)
Analyst comments:
- MOS -2.1% (downgraded to Neutral from Overweight at JP Morgan)
- VZ -2% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- EBAY -1.8% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- AMT -0.6% (downgraded to Equal-Weight from Overweight at Morgan Stanley)